An insulin receptor-binding multifunctional protein from tamarindus indica L. presents a hypoglycemic effect in a diet-induced type 2 diabetes-preclinical study

• Autor(a) principal: Maciel, Bruna Leal Lima
• Data de Publicação: 2022
• Outros Autores: Costa, Izael de Sousa, Lima, Mayara Santos Rosa, Medeiros, Amanda, Bezerra, Lucas Lima, Santos, Paula, Serquiz, Alexandre, Lima, Maíra Conceição Jerônimo de Souza, Oliveira, Gerciane Santos de, Santos, Elizeu Antunes dos, Monteiro, Norberto de Kássio Vieira, Morais, Ana Heloneida
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRN
• Texto Completo: https://repositorio.ufrn.br/handle/123456789/57445; http://dx.doi.org/10.3390/foods11152207
• topic: Trypsin inhibitor; Tamarind; Hypoglycemic agent; Plant proteins; Molecular docking simulation

The objectives of this study were to evaluate the hypoglycemic effect of the trypsin inhibitor isolated from tamarind seeds (TTI) in an experimental model of T2DM and the in silico interaction between the conformational models of TTI 56/287 and the insulin receptor (IR). After inducing T2DM, 15 male Wistar rats were randomly allocated in three groups (n = 5): 1—T2DM group without treatment; 2—T2DM group treated with adequate diet; and 3—T2DM treated with TTI (25 mg/kg), for 10 days. Insulinemia and fasting glucose were analyzed, and the HOMA-IR and HOMA-β were calculated. The group of animals treated with TTI presented both lower fasting glucose concentrations (p = 0.0031) and lower HOMA-IR indexes (p = 0.0432), along with higher HOMA-β indexes (p = 0.0052), than the animals in the other groups. The in silico analyses showed that there was an interaction between TTIp 56/287 and IR with interaction potential energy (IPE) of −1591.54 kJ mol−1 (±234.90), being lower than that presented by insulin and IR: −894.98 kJ mol−1 (±32.16). In addition, the presence of amino acids, type of binding and place of interaction other than insulin were identified. This study revealed the hypoglycemic effect of a bioactive molecule of protein origin from Tamarind seeds in a preclinical model of T2DM. Furthermore, the in silico analysis allowed the prediction of its binding in the IR, raising a new perspective for explaining TTI’s action on the glycemic response